Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs VENUS REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA VENUS REMEDIES AJANTA PHARMA/
VENUS REMEDIES
 
P/E (TTM) x 38.3 15.0 254.9% View Chart
P/BV x 8.3 0.9 877.7% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AJANTA PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
VENUS REMEDIES
Mar-23
AJANTA PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,426379 376.3%   
Low Rs1,062145 732.6%   
Sales per share (Unadj.) Rs297.2415.5 71.5%  
Earnings per share (Unadj.) Rs46.719.9 235.0%  
Cash flow per share (Unadj.) Rs57.144.0 129.7%  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.1344.3 78.1%  
Shares outstanding (eoy) m125.9113.37 941.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.20.6 664.0%   
Avg P/E ratio x26.613.2 202.1%  
P/CF ratio (eoy) x21.85.9 366.3%  
Price / Book Value ratio x4.60.8 607.9%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,6383,501 4,473.5%   
No. of employees `000NANA-   
Total wages/salary Rs m7,851570 1,376.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,4265,555 673.7%  
Other income Rs m986103 955.6%   
Total revenues Rs m38,4135,658 678.9%   
Gross profit Rs m7,833602 1,301.1%  
Depreciation Rs m1,308323 405.0%   
Interest Rs m583 1,986.4%   
Profit before tax Rs m7,453379 1,964.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573114 1,383.8%   
Profit after tax Rs m5,880266 2,213.3%  
Gross profit margin %20.910.8 193.1%  
Effective tax rate %21.130.0 70.4%   
Net profit margin %15.74.8 328.5%  
BALANCE SHEET DATA
Current assets Rs m28,2523,230 874.8%   
Current liabilities Rs m11,393826 1,379.8%   
Net working cap to sales %45.043.3 104.1%  
Current ratio x2.53.9 63.4%  
Inventory Days Days6637 178.3%  
Debtors Days Days10504 2.0%  
Net fixed assets Rs m18,7072,781 672.6%   
Share capital Rs m253134 189.0%   
"Free" reserves Rs m33,6244,470 752.3%   
Net worth Rs m33,8774,603 735.9%   
Long term debt Rs m13387 3.2%   
Total assets Rs m47,0476,011 782.7%  
Interest coverage x128.6130.0 98.9%   
Debt to equity ratio x00.1 0.4%  
Sales to assets ratio x0.80.9 86.1%   
Return on assets %12.64.5 282.5%  
Return on equity %17.45.8 300.8%  
Return on capital %22.27.7 289.3%  
Exports to sales %59.90-   
Imports to sales %11.50-   
Exports (fob) Rs m22,420NA-   
Imports (cif) Rs m4,293NA-   
Fx inflow Rs m22,4200-   
Fx outflow Rs m4,2930-   
Net fx Rs m18,1270-   
CASH FLOW
From Operations Rs m7,918366 2,161.7%  
From Investments Rs m-5,596-508 1,100.9%  
From Financial Activity Rs m-1,079-6 18,991.2%  
Net Cashflow Rs m1,243-220 -563.9%  

Share Holding

Indian Promoters % 66.2 41.8 158.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 1.6 1,621.4%  
FIIs % 9.1 1.6 573.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 58.2 58.0%  
Shareholders   54,351 19,560 277.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs VENUS REMEDIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs VENUS REMEDIES Share Price Performance

Period AJANTA PHARMA VENUS REMEDIES S&P BSE HEALTHCARE
1-Day 2.51% 7.05% 1.18%
1-Month 7.60% -4.10% -0.75%
1-Year 92.91% 103.11% 61.82%
3-Year CAGR 21.63% 4.62% 18.16%
5-Year CAGR 26.85% 58.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the VENUS REMEDIES share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of VENUS REMEDIES.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of VENUS REMEDIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.